Translational Conference Agenda
April 6-8, 2010
BentonConvention Center, Winston-Salem, NC
Strategies for Healthcare Innovation and Personalized Medicine
About the Forum
The Translational Regenerative Medicine Forum is designed as the premiere event for leaders in regenerative medicine translation, representing academic and clinical research, regulatory and reimbursement policy, venture investment and biotechnology industry interests. In order to facilitate business development opportunities and investment, the meeting will feature a venture forum showcasing 18 regenerative medicine companies.
Agenda
Tuesday, April 6th |
||
| 4:00–6:00 pm | Conference Registration and Networking | |
| 6:00–7:30 pm | Opening Reception | |
Wednesday, April 7th |
||
| 7:30–8:30 am | Networking Breakfast | |
| 8:30–8:45 am | Welcome and Opening Remarks | |
| Welcome | Anthony Atala, MD, Wake Forest Institute for Regenerative Medicine |
|
| 8:45–9:15 am | What Is the Promise of Regenerative Medicine? | |
| Format: Panel | ||
| Moderator | John E. Abele, Founding Chairman, Retired, Boston Scientific Corporation |
|
| Panelist | Alan J. Lewis, PhD, Juvenile Diabetes Research Foundation International |
|
| Panelist | John Walker, iPierian | |
| Panelist | Andrew von Eschenbach, MD, Greenleaf Health LLC and Center for Health Transformation Former US FDA Commissioner |
|
| Panelist | Gary J. Kurtzman, MD, Safeguard Scientifics |
|
| 9:15–10:00 am | The Translational Imperative: Deliver the Promise | |
| Format: Panel | ||
| Moderator | Lesa Mitchell, Kauffman Foundation |
|
| Panelist | Brock Reeve, MPhil, MBA, Harvard Stem Cell Institute |
|
| Panelist | Scott Weir, PharmD, PhD, University of Kansas, Institute for Advancing Medical Innovation |
|
| Panelist | Rick Blume, Excel Medical Ventures | |
| 10:00–10:30 am | Networking Break | |
| 10:30–11:15 am | The Science: What’s Next for the Clinic? | |
| Format: Plenary, Keynote Address | Robert Lanza, MD, Advanced Cell Therapy |
|
| 11:15 am–noon | Bridging: From the Bench to the Bedside | |
| Format: Panel | ||
| Moderator | Michael J. Werner, Holland & Knight |
|
| Panelist | Bernard Siegel, Genetics Policy Institute |
|
| Panelist | COL Janet R. Harris, PhD, MSN, AFIRM Congressionally Directed Medical Research Programs |
|
| Panelist | DaLaura L.S. Kader, Regenerative Medicine Foundation |
|
| Panelist | Michelle McMurry-Heath, MD, PhD, The Aspen Institute |
|
| Panelist | Rosemarie Hunziker, PhD, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health |
|
| noon–12:30 pm | Lunch | |
| 12:30–1:15 pm | A Funding Model for Translational Medicine | |
| Format: Keynote Address | Robert Klein, California Institute for Regenerative Medicine (CIRM) |
|
| 1:15–2:00 pm | Integrative Commercialization Strategies | |
| Format: Panel | ||
| Moderator | Scott R. Burger, MD, Advanced Cell & Gene Therapy |
|
| Panelist | Stephen Minger, PhD, GE Healthcare |
|
| Panelist | Steven R. Bauer, PhD, US Food and Drug Administration |
|
| Panelist | Vincent Ronfard, PhD, Organogenesis |
|
| Panelist | Joydeep Goswami, PhD, MBA, Life Technologies |
|
| Panelist | Tim Bertram, DVM, PhD, Tengion | |
| 2:00–2:45 pm | Regulatory and Reimbursement Strategies | |
| Format: Panel | ||
| Moderator | Andrew von Eschenbach, MD, Greenleaf Health LLC and Center for Health Transformation Former US FDA Commissioner |
|
| Panelist | Steven R. Bauer, PhD, US Food and Drug Administration |
|
| Panelist | Anthony Ratcliffe, PhD, Synthasome |
|
| Panelist | Robert P. Brady, Hogan & Hartson | |
| Panelist | Richard E. Caruso, PhD, Integra | |
| 2:45–3:15 pm | International Best Practices in Regenerative Medicine | |
| Format: Panel | ||
| Moderator | David F. Williams, DSc, FREng, Wake Forest Institute for Regenerative Medicine |
|
| Panelist | Prof. Chunren Wang, National Institute for the Control of Pharmaceutical and Biological Products |
|
| Panelist | COL Robert Vandre, DDS, AFIRM | |
| Panelist | Mime Egami, PhD, Tokyo Women’s Medical University |
|
| 3:15–3:35 pm | Networking Break | |
| 3:35–5:30 pm | Scientific Discovery | |
| Format: Podium Presentations | ||
| Host and Presenter | Buddy D. Ratner, PhD, University of Washington |
|
| Presenter | Teruo Okano, PhD, Tokyo Women’s Medical University |
|
| Presenter | Jennifer H. Elisseeff, PhD, Johns Hopkins University |
|
| Presenter | Jack Kessler, MD, Northwestern University |
|
| Presenter | G. Sitta Sittampalam, PhD, University of Kansas, Institute for Advancing Medical Innovation |
|
| Presenter | Douglas Losordo, MD, FACC, Northwestern University | |
| Presenter | Camillo Ricordi, MD, Diabetes Research Institute, University of Miami Miller School of Medicine |
|
| Presenter | Simon Cool, PhD, A*STAR Singapore |
|
| Presenter | B. Lynn Allen-Hoffmann, PhD, Stratatech Corporation |
|
| Presenter | Yilin Cao, MD, PhD, Shanghai Jiao Tong University |
|
| 5:30–6:30 pm | Networking Reception | |
| Poster Session | ||
| 7:00–8:30 pm | Gala Dinner | |
| Keynote Address: | Juan Enriquez, Excel Venture Management |
|
Thursday, April 8th |
||
| 7:00–8:00 am | Breakfast and Venture Forum I | |
| Company | Arterion | |
| Company | Articular Engineering | |
| Company | Creative Bioreactor Designs, Inc. | |
| Company | ISTO Technologies | |
| Company | KeraNetics | |
| Company | Kryosphere | |
| Company | Southern Access Technologies | |
| Company | Ventrix | |
| 8:00–8:30 am | Regenerative Medicine and the U.S. Military | |
| Format: Plenary, Keynote Address | ||
| Lieutenant General Eric B. Schoomaker, MD, PhD, US Army Medical Command |
||
| 8:30–9:15 am | Best Practices in Commercialization | |
| Format: Panel | ||
| Moderator | R. Lee Buckler, BEd, LLB, Cell Therapy Group |
|
| Panelist | Anthony Caggiano, MD, PhD, Acorda Therapeutics |
|
| Panelist | Dean Tozer, Advanced BioHealing |
|
| Panelist | Ed Field, Aldagen | |
| Panelist | Robert Deans, PhD, Athersys | |
| Panelist | Richard S. Stack, MD, FACC, Synecor |
|
| 9:15–9:45 am | Commercial Capacity and Tools | |
| Format: Panel | ||
| Moderator | Edmund “Morrie” Ruffin, MA, Adjuvant Global Advisors |
|
| Panelist | Raymond H. Cypess, DVM, PhD, ATCC |
|
| Panelist | Joseph DeSimone, PhD, Liquidia Technologies |
|
| Panelist | Kurt Last, Specialty Operations Solutions |
|
| Panelist | David S. Smith, Pepper Hamilton LLP |
|
| 9:45–10:20 am | Venture Panel I: Designing the Deal | |
| Format: Panel | ||
| Moderator | Jeff Karan, MBA Proteus Ventures Partners |
|
| Panelist | Garheng Kong, MD, PhD, Intersouth Partners |
|
| Panelist | Frank Douglas, MD, PhD, Pure Tech Ventures, Austen BioInnovation Inst. in Akron, Kauffman Foundation |
|
| Panelist | Timothy Coetzee, PhD, Fast Forward |
|
| Panelist | Mostafa Analoui, PhD, Livingston Group |
|
| Panelist | Gail K. Naughton, PhD, Histogen |
|
| 10:20–11:00 am | Venture Panel II: Capturing Value for Capital Markets | |
| Format: Panel | ||
| Panelist | Jay Watkins, De Novo Ventures |
|
| Panelist | Scott Livingston, Livingston Securities |
|
| Panelist | Rick Blume, Excel Medical Ventures |
|
| Panelist | P. Sherrill Neff, Quaker BioVentures |
|
| Panelist | David Scheer, Scheer & Company |
|
| 11:00–11:15 am | Networking Break | |
| 11:15 am–12:55 pm | Venture Forum II | |
| Company | ACell | |
| Company | Avita Medical | |
| Company | Bioheart | |
| Company | Healionics | |
| Company | Juventas Therapeutics | |
| Company | Ocular Systems | |
| Company | PharmInova | |
| Company | Soft Tissue Regeneration | |
| Company | America Stem Cell | |
| Company | Axerion Therapeutics | |
| 12:55–1:00 pm | Wrap Up and Adjourn Meeting | Anthony Atala, MD, Wake Forest Institute for Regenerative Medicine |
